Cheryl Meyerkord Belton
Cheryl Meyerkord Belton
Dr. Cheryl Meyerkord, shown with a pre-defense gift, successfully defended her dissertation on February 9, 2009. Cheryl completed her postdoc with Dr. Haian Fu, Emory University School of Medicine while also serving as the Administrative Project Manager for the Emory Chemical Biology Discovery Center. Following a year as a Research Associate, Cheryl became Content Editor for EB Medicine, the leading publisher of evidence-based diagnosis and treatment recommendations to help emergency clinicians provide the best patient care.
Cheryl received the Outstanding Graduate Student Award at the 2008 Moffitt Scientific Retreat.
Takahashi Y, Meyerkord CL, Wang HG. Bif-1/endophilin B1: a candidate for crescent driving force in autophagy. Cell Death Differ. 2009 Jul;16(7):947-55. doi: 10.1038/cdd.2009.19. Epub 2009 Mar 6. Review. PMID: 19265852
Dr. Meyerkord's publication record while in the Program:
Takahashi Y, Meyerkord CL, Wang HG. BARgaining membranes for autophagosome formation: Regulation of autophagy and tumorigenesis by Bif-1/Endophilin B1. Autophagy. 2008 Jan-Feb;4(1):121-4.
Meyerkord CL, Takahashi Y, Takada N, Weiss R, Wang HG. Loss of HUS1 Sensitizes Cells to Etoposide-Induced Apoptosis by Regulating BH3-Only Proteins. Oncogene. 15 Sept 2008.
Araya R, Hirai I, Meyerkord CL, Wang HG. Loss of RPA 1 induces Chk2 phosphorylation through a caffeine-sensitive pathway. FEBS Lett. 2005 Jan 3; 579(1):157-61.
Dr. Meyerkord's publication record since graduation:
Takahashi Y, Meyerkord CL, Hori T, Runkle K, Fox TE, Kester M, Loughran TP, Wang HG. Bif-1 regulates Atg9 trafficking by mediating the fission of Golgi membranes during autophagy. Autophagy. 2011 Jan;7(1):61-73. Epub 2011 Jan 1. PMID: 21068542
Zhao J, Meyerkord CL, Du Y, Khuri FR, Fu H.14-3-3 proteins as potential therapeutic targets. Semin Cell Dev Biol. 2011 Oct 1.
Runkle KB, Meyerkord CL, Desai NV, Takahashi Y, Wang HG. Bif-1 suppresses breast cancer cell migration by promoting EGFR endocytic degradation. Cancer Biol Ther. 2012 Aug;13(10):956-66. doi: 10.4161/cbt.20951. Epub 2012 Aug 1. PMID: 22785202
Qi Q, He K, Liu X, Pham C, Meyerkord C, Fu H, Ye K. Disrupting the PIKE-A/Akt interaction inhibits glioblastoma cell survival, migration, invasion and colony formation. Oncogene. 2013 Feb 21;32(8):1030-40. PMID: 22450747